Viral Kinetics Analysis and Virological Characterization of Treatment Failures in Patients With Chronic Hepatitis C Treated With Sofosbuvir and an NS5A Inhibitor

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Gastroenterology
HepatologyGastroenterology
2019English

Liver Toxicity Associated With Sofosbuvir, an NS5A Inhibitor and Ribavirin Use

Journal of Hepatology
Hepatology
2016English

Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir

International Journal of Current Microbiology and Applied Sciences
2018English

Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia

American Journal of Hematology
Hematology
2018English

Sociodemographic and Clinical Characterization of Patients With Chronic Hepatitis C

Enfermeria Global
Nursing
2019English

Treatment Efficacy of All-Oral Combinations of Direct-Acting Antivirals in Chronic Hepatitis C Patients With NS5A-P32 Deletion

Acta Hepatologica Japonica
Hepatology
2017English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

JAMA - Journal of the American Medical Association
Medicine
2014English

Histological Response Study of Chronic Viral Hepatitis C Patients Treated With Interferon Alone or Combined With Ribavirin

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy